PT  - JOURNAL ARTICLE
AU  - Kaseka, Paul Uchizi
AU  - Kayira, Alfred
AU  - Chimbatata, Chikondi Sharon
AU  - Chisale, Master
AU  - Kamudumuli, Pocha
AU  - Wu, Tsung-Shu Joseph
AU  - Mbakaya, BalwaniChingatichifwe
AU  - Sinyiza, Frank Watson
TI  - Histopathological Profile of Cervical Biopsies in Northern Malawi: A Retrospective Study
AID  - 10.1101/2020.12.28.20248949
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.12.28.20248949
4099  - http://medrxiv.org/content/early/2021/01/04/2020.12.28.20248949.short
4100  - http://medrxiv.org/content/early/2021/01/04/2020.12.28.20248949.full
AB  - Objectives This study was carried out to determine the histopathological profile of cervical biopsies in a public tertiary hospital in Mzuzu, northern region of Malawi.Setting A public tertiary hospital in Mzuzu, northern region of MalawiParticipants This was a retrospective study of all cervical biopsy specimen reports received in a public tertiary hospital in northern Malawi over a period of 5 years from July 2013-June 2018. Eleven reports which had missing demographic and clinical data or had inconclusive results were excluded. Demographic, clinical and histopathological data was obtained from original histology reports.Results A total of 500 cervical biopsy reports were reviewed during the study period. The mean age of the patients was 41.99±12.5. Age ranged from 15 to 80 years. Cervicitis accounted for 46.0% (n=162) of the total nonmalignant lesions seen, followed by cervical intraepithelial neoplasm (CIN), at 24.4% (n=86) and endocervical polyp, at 20.5% (n=72). Squamous cell carcinoma (SCC) accounted for 15.6% (n=78) of the total cervical biopsies studied and 85.7% of all total malignant lesions. All malignant tumours had HIV.Conclusion Our study shows that cervicitis and squamous cell carcinoma were most common among nonmalignant and malignant cervical biopsies respectively. Since the frequency of cervical cancer is high, there is need to have well detailed national policies to be put in place to increase detection of pre-invasive lesions in order to reduce the prevalence of cervical cancer.Strengths and limitation of this study Strengths This paper has shownThe need for well detailed national policies to be put in place to increase detection of pre-invasive lesions, which in turn will decrease the frequency of cervical cancer in the country.The importance of intensifying cervical cancer screening programmes among women and provision of long term ART to the HIV infected which may offer an opportunity for appropriate interventions to reduce morbidity, mortality and reduce complications among these women.LimitationsThis study used available programme health facility data and histopathological reports on cervical cancer which has its own limitations, such as incompleteness and bias in the sense that information is obtained only from people who came to the facility and underwent biopsy, leaving out those that did not seek medical care and or were not biopsied and therefore cannot be generalized to the general population.The study is a single-hospital-based review and as such inadequate to draw conclusions, but it does shed some light on pathological pattern of cervical cancer in Malawi.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study data collection, analysis, interpretation of data and manuscript writing was funded by Pingtung Christian Hospital, Taiwan through Luke International Norway (LIN), Malawi, Grant Number: PS-IR-108001Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by National Health Science Research Committee as part of the main study Pathological profile of malignancies in northern Malawi-A retrospective study at Mzuzu Central Hospital number 19/05/2316.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data relevant to the study are included in the article and Data are available upon reasonable request from the corresponding author using the following contacts email: kasekapaul2016@gmail.com ORCID: 0000-0002-6651-8000